Today: 21 May 2026
Browse Category

NSE:VI 3 November 2025 - 18 December 2025

Vodafone Idea Share Price Today (Dec 18, 2025): Vi Stock Rises Again as AGR Relief Talk, Funding Moves and Analyst Forecasts Drive Focus

Vodafone Idea Share Price Today (Dec 18, 2025): Vi Stock Rises Again as AGR Relief Talk, Funding Moves and Analyst Forecasts Drive Focus

Vodafone Idea shares rose about 3% to ₹11.49 on December 18, trading near their 52-week high amid heavy volumes on NSE and BSE. The rally follows recent Supreme Court signals that the government may consider broader relief on the company’s AGR dues. Market capitalization hovered around ₹1.24 lakh crore. Investors remain focused on potential changes to Vodafone Idea’s statutory payment obligations.
18 December 2025
·
Vodafone Idea Share Price Hits a New 52-Week High on AGR Moratorium Buzz — Latest News, Analyst Targets, and What Could Move Vi Stock Next

Vodafone Idea Share Price Hits a New 52-Week High on AGR Moratorium Buzz — Latest News, Analyst Targets, and What Could Move Vi Stock Next

Vodafone Idea shares hit a 52-week high of ₹12.03 on Monday after reports that the government may offer a 4–5 year interest-free moratorium on over ₹83,000 crore in AGR dues. The stock later pared gains as investors awaited Cabinet-level confirmation. Vodafone Idea has not issued any new official statement on the relief package.
15 December 2025
·

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop